| Active, not recruiting | 3 | 751 | Europe, Canada, US, RoW | temozolomide, Temodar, Temodal, DNA methylation analysis, laboratory biomarker analysis, adjuvant therapy, quality-of-life assessment, radiation therapy | European Organisation for Research and Treatment of Cancer - EORTC, NCIC Clinical Trials Group, Radiation Therapy Oncology Group, Medical Research Council, Merck Sharp & Dohme LLC | Brain and Central Nervous System Tumors | 09/18 | 12/29 | | |
| Active, not recruiting | 1/2 | 30 | Europe | VXM01, Investigational VEGFR-2 DNA Vaccine, Avelumab, Bavencio | Vaximm GmbH, Merck KGaA, Darmstadt, Germany, Pfizer | Recurrent Glioblastoma | 12/21 | 12/22 | | |
